| 重型/危重型新型冠状病毒肺炎关键治疗技术研究进展 |
| |
| 引用本文： | 潘彤彤,陈永平. 重型/危重型新型冠状病毒肺炎关键治疗技术研究进展[J]. 中国生物工程杂志, 2020, 40(1-2): 78-83. DOI: 10.13523/j.cb.2002004 |
| |
| 作者姓名： | 潘彤彤 陈永平 |
| |
| 作者单位： | 温州医科大学附属第一医院感染内科 浙江省慢性肝病重症化精准诊治与转化重点实验室 温州医科大学肝病研究所 温州 325035 |
| |
| 摘 要： | 新型冠状病毒(SARS-CoV-2)引发的肺炎疫情严重威胁广大人民群众身体健康和生命安全,对我国的经济发展和社会稳定产生重大影响。由于新型冠状病毒的传染性强、传播速度快、致死率较高,且尚无有效疫苗和药物来防治,少数患者迅速进展为重型、危重型甚至死亡。如何精准抗SARS-CoV-2、阻断新冠肺炎进展并改善患者预后是当下医药卫生界的研究热点。主要围绕重型、危重型新冠肺炎最新治疗手段研究进展进行综述。
|
| 关 键 词： | SARS-CoV-2 抗病毒药 人工肝治疗 细胞免疫疗法 肠道微生态 |
| 收稿时间： | 2020-02-07 |
Research Progress of Key Techniques for Severe/Critical Type of Novel Coronavirus Pneumonia |
| |
| PAN Tong-tong,CHEN Yong-ping. Research Progress of Key Techniques for Severe/Critical Type of Novel Coronavirus Pneumonia[J]. China Biotechnology, 2020, 40(1-2): 78-83. DOI: 10.13523/j.cb.2002004 |
| |
| Authors: | PAN Tong-tong CHEN Yong-ping |
| |
| Abstract: | The pneumonia epidemic caused by the new coronavirus (SARS-CoV-2) seriously threatens the health and life of the general public, and has a major impact on China’s economic development and social stability. Because the new coronavirus is highly contagious, spreads fast, and has a high lethality rate, there are no effective vaccines and drugs to prevent and treat it. A small number of patients have developed severe and critical illness or even died. How to accurately resist and block the progression of new coronary pneumonia, and improve the prognosis of patients is the current research hotspot in the medical and health field. This article reviews the recent advances in the latest treatments for pneumonia in severe and critically new coronavirus infections. |
| |
| Keywords: | SARS-CoV-2 Antiviral agent Artificial extracorporeal liver support Cellular immunotherapy Gut microecology |
|
| 点击此处可从《中国生物工程杂志》浏览原始摘要信息 |
|
点击此处可从《中国生物工程杂志》下载全文 |
